Dhruva Biswas, MA, PhD, MBBS

Dr. Biswas is a Clinician-Data Scientist at the Cardiovascular Data Science (CarDS) Lab and an Associate Research Scientist at the Yale School of Medicine. His research aims to integrate AI-driven insights into clinical practice. This includes developing digital and molecular biomarkers to identify high-risk patients who are currently overlooked, evaluating the clinical contexts in which algorithm performance may be improved, and depicting the underlying pathophysiological mechanisms.

Dr. Biswas has authored publications in several peer-reviewed journals, including first author articles in Nature Medicine and Nature Cancer. His work has been featured in media outlets including The Times, the Independent, and Yahoo News. He has been recognized as ‘at the forefront of medical research’ by Nature Medicine ’19.

Dr. Biswas started his medical training at the University of Cambridge in 2012, taking a MA in Neuroscience in 2015. Next, he joined the MB/PhD programme at University College London, undertaking PhD research between UCL Cancer Institute and the Francis Crick Institute. His thesis work was recognized with international prizes, and he was also recognized as a Francis Crick Institute Translation Fellow for acting as a role model in the translational medicine community. He graduated with PhD and MBBS degrees in 2022. Dr. Biswas then secured an Academic Foundation training position in the Cardiology stream at King’s College London. During his two-year medical internship, he also worked as a Postdoctoral Fellow at University College London.

In addition to his research and clinical duties, Dr. Biswas is passionate about mentorship and community engagement. He has supervised several MSc students, all of whom achieved distinction grades, and with three nominated for the Dean's Research Prize for the top project mark in their respective cohorts. He is also committed to patient and public involvement, including being involved with the South London structural heart team looking at equity of access to life-prolonging procedures.